Search results for "cerebral infarct"

showing 10 items of 84 documents

“Accent issue”: foreign accent syndrome following ischemic stroke

2019

Background: Foreign accent syndrome (FAS) is arare syndrome associated with altered speech rhythm and prosody, which listeners perceive as foreign; cerebrovascular accidents, tumors and multiple sclerosis are reported as possible causes of FAS. The pathophysiology of FAS is not yet understood. Case presentation: A 68-year-old Italian man was admitted to the EmergencyDepartment for non-fluent aphasia and dysarthria. Computed tomography (CT) scan did not show abnormalities; the patient was treated with systemic thrombolysis. A repeated brain CT and magnetic resonance imaging (MRI) confirmed an infarct in the left primary motor cortex and mild extension to cortico-subcortical frontal regions. …

Foreign accent syndromeMalemedicine.medical_specialtyNeurologyDermatologyProsodyAudiology03 medical and health sciencesDysarthria0302 clinical medicineAphasiaStress (linguistics)Motor speech disordersmedicineAphasiaHumans030212 general & internal medicineStrokeNeuroradiologyAgedSpeech disordersbusiness.industryMotor CortexGeneral MedicineCerebral Infarctionmedicine.diseaseForeign accent syndromeStrokePsychiatry and Mental healthSettore MED/26 - NeurologiaNeurology (clinical)medicine.symptombusiness030217 neurology & neurosurgery
researchProduct

Functional electrical therapy for hemiparesis alleviates disability and enhances neuroplasticity

2011

Impaired motor and sensory function is common in the upper limb in humans after cerebrovascular stroke and it often remains as a permanent disability. Functional electrical stimulation therapy is known to enhance the motor function of the paretic hand; however, the mechanism of this enhancement is not known. We studied whether neural plasticity has a role in this therapy-induced enhancement of the hand motor function in 20 hemiparetic subjects with chronic stroke (age 53 ± 6 years; 7 females and 13 males; 10 with cerebral infarction and 10 with cerebral haemorrhage; and time since incident 2.4 ± 2.0 years). These subjects were randomized to functional electrical therapy or conventional phys…

Male030506 rehabilitationmedicine.medical_specialtymedicine.medical_treatmentNeural ConductionElectric Stimulation TherapyGeneral Biochemistry Genetics and Molecular Biology03 medical and health sciences0302 clinical medicinePhysical medicine and rehabilitationNeuroplasticitymedicineHumansFunctional electrical stimulationStrokeAnalysis of VarianceNeuronal Plasticitybusiness.industryCerebral infarctionMotor controlGeneral MedicineMiddle AgedHandmedicine.diseaseTranscranial Magnetic StimulationParesisStrokeTranscranial magnetic stimulationHemiparesisPhysical therapyFemalePrimary motor cortexmedicine.symptom0305 other medical sciencebusiness030217 neurology & neurosurgery
researchProduct

Cerebral metabolism after transient ischemic attack. A 1H MR spectroscopy study

1999

International audience; Abstract: Metabolic changes induced by cerebral infarction or by stenosis and occlusion of the internal carotid artery have been previously described in 1H Magnetic Resonance Spectroscopy (1H MRS). These changes are essentially characterized by decreased N-acetyl-aspartate (NAA) and increased lactate concentration. Little is known about the metabolic changes observed in the three days following a transient ischemic attack (TIA) in the absence of stenosis or occlusion of the internal carotid artery, and without visible infarction on Magnetic Resonance imaging (MRI). We studied five patients with a TIA lasting between 30 min and 3 h, affecting the sensory and motor fun…

Male1h nmr spectroscopymedicine.medical_specialtyMagnetic Resonance SpectroscopyProton Magnetic Resonance Spectroscopyeducation[INFO.INFO-IM] Computer Science [cs]/Medical ImagingCerebral metabolism030218 nuclear medicine & medical imaging03 medical and health sciences0302 clinical medicineInternal medicinemedicine.arteryOcclusion[INFO.INFO-IM]Computer Science [cs]/Medical ImagingmedicineHumansLactic Acidcardiovascular diseasesAgedCerebral Cortex[ INFO.INFO-IM ] Computer Science [cs]/Medical ImagingCerebral infarctionbusiness.industryGeneral MedicineMiddle AgedCreatinemedicine.diseaseMagnetic Resonance Imaging3. Good healthStenosisNeurologyIschemic Attack Transienttransient ischemic attackcardiovascular systemCardiologycarotid stenosisFemalesense organsNeurology (clinical)RadiologyProtonsInternal carotid arteryTomography X-Ray Computedbusiness030217 neurology & neurosurgery
researchProduct

Gait reveals bilateral adaptation of motor control in patients with chronic unilateral stroke.

2008

Background and aims: Functional brain imaging has shown that bilateral brain reorganization may occur after unilateral cerebral damage. The present study searched for evidence of bilateral motor control changes in gait in patients with chronic unilateral stroke. Methods: Gait variables (temporal and spatial parameters, footprint peak times (FPPT) and footfall times (FFT)) were recorded in 48 patients with chronic unilateral stroke at their preferred speed, and in 10 healthy volunteers walking from very slowly to very fast on a pressure sensor walkway. The data were divided into 4 groups according to gait velocity. The functional outcome of stroke was measured by the Barthel Index. Results: …

MaleAgingmedicine.medical_specialtyAdaptation (eye)Functional LateralityPhysical medicine and rehabilitationmedicineHumansAsymmetry IndexStrokeGaitCerebral HemorrhageAnalysis of VarianceMotor controlBrainCerebral InfarctionMiddle Agedmedicine.diseaseGaitAdaptation PhysiologicalParesisStrokeHemiparesisGait analysisCase-Control StudiesChronic DiseaseFemaleAnalysis of varianceGeriatrics and Gerontologymedicine.symptomPsychologyhuman activitiesAging clinical and experimental research
researchProduct

Inhibition of iNOS activity by 1400W decreases glutamate release and ameliorates stroke outcome after experimental ischemia

2005

Background and purpose. It has been shown that the reversed operation of glutamate transporters when ATP levels fall accounts for most glutamate release induced by severe cerebral ischemia. Nitric oxide (NO) is formed after ischemia and causes ATP depletion. Our purpose is to test if NO release from inducible NO synthase (iNOS) after stroke may cause a delayed glutamate release due to ATP depletion that might underlie progression of the ischemic infarct. We have studied the effect of the highly selective inhibitor of iNOS activity 1400W on brain ATP levels, extracellular glutamate, and stroke outcome after transient focal cerebral ischemia in rats. Methods. To induce focal ischemia, the mid…

MaleBenzylaminesAmino Acid Transport System X-AGIschemiaAmidinesInfarctionDown-RegulationGlutamic AcidNitric Oxide Synthase Type IIL-argininePharmacologyNeuroprotectionNitric oxidelcsh:RC321-571chemistry.chemical_compoundAdenosine TriphosphateWestern blotmedicine.arteryStroke outcomeMedicineAnimalscardiovascular diseasesEnzyme InhibitorsRats Wistarlcsh:Neurosciences. Biological psychiatry. Neuropsychiatrymedicine.diagnostic_testbusiness.industryGlutamate receptorBrainInfarction Middle Cerebral ArteryNitric oxideCerebral Infarctionmedicine.diseaseNeuroprotectionRatsATPStrokeDisease Models AnimalNeuroprotective AgentsTreatment OutcomeNeurologychemistryCytoprotectionIschemic Attack TransientAnesthesiaMiddle cerebral arteryNitric Oxide SynthaseGlutamatebusinessNeurobiology of Disease
researchProduct

Novel complement C1 inhibitor BSF468248 does not improve brain damage after cortical vein occlusion

2003

BSF468248 is a novel potent complement C1 inhibitor. To determine whether BSF468248 is effective against focal cerebral ischemia, we evaluated the change of cerebral blood flow (CBF) and infarction volume using a photochemically-induced cortical vein occlusion model in rats in blind studies. In 22 Wistar rats, two adjacent cortical veins were occluded by photochemical thrombosis and fiberoptic illumination under controlled anesthesia and ventilation. Just after the occlusion, BSF468248 or physiological saline was administrated. In the low-dose study, a treatment group (n = 7) was administered BSF468248 1 mg/kg bolus and 1 mg/kg continuously for 30 min. The same volume of saline was given to…

MaleCerebral veinsPhotochemistrymedicine.medical_treatmentComplement C1 Inactivator ProteinsRats Sprague-DawleyBolus (medicine)OcclusionmedicineAnimalsRats WistarInfusions IntravenousSalineCerebral Cortexbusiness.industryCerebral InfarctionBlood flowCortical Veinmedicine.diseaseCerebral VeinsThrombosisRatsDisease Models AnimalTreatment OutcomeCerebral blood flowRegional Blood FlowBrain InjuriesCerebrovascular CirculationAnesthesiaIntracranial ThrombosisbusinessOligopeptidesMethods and Findings in Experimental and Clinical Pharmacology
researchProduct

''Effect of stroke on arginase expression and localization in the rat brain''

2013

Quirie, Aurore | Demougeot, C. Eline | Bertrand, Nathalie | Mossiat, Claude | Garnier, Philippe | Marie, Christine | Prigent-Tessier, Anne; International audience; ''Because arginase and nitric oxide (NO) synthases (NOS) compete to degrade l-arginine, arginase plays a crucial role in the modulation of NO production. Moreover, the arginase 1 isoform is a marker of M2 phenotype macrophages that play a key role in tissue remodeling and resolution of inflammation. While NO has been extensively investigated in ischemic stroke, the effect of stroke on the arginase pathway is unknown. The present study focuses on arginase expression/activity and localization before and after (1, 8, 15 and 30days) …

MaleGene Expressionchemistry.chemical_compound0302 clinical medicineNeurotrophic factorsMACROPHAGESIN-VIVONeuronsAXONAL REGENERATION0303 health sciencesGlial fibrillary acidic proteinGeneral NeuroscienceBrainGLIAL RESPONSESCerebral InfarctionStrokeNitric oxide synthaseArginasemedicine.anatomical_structureBiochemistry[ SCCO.NEUR ] Cognitive science/NeuroscienceARGININE METABOLISMmedicine.symptom2'-DIPYRIDYLmedicine.medical_specialtyCentral nervous systemIRON CHELATOR 2InflammationBiologyFOCAL ISCHEMIANitric oxideLesion03 medical and health sciencesInternal medicineGlial Fibrillary Acidic ProteinmedicineAnimalsRats WistarNITRIC-OXIDE SYNTHASE030304 developmental biologyArginaseCEREBRAL-ISCHEMIABrain-Derived Neurotrophic Factor[SCCO.NEUR]Cognitive science/NeuroscienceCENTRAL-NERVOUS-SYSTEM''NITRIC-OXIDE SYNTHASERatsEndocrinologychemistryAstrocytesbiology.proteinMACROPHAGES''030217 neurology & neurosurgery
researchProduct

Neuroprotective effect of ceftriaxone on the penumbra in a rat venous ischemia model.

2012

Glutamate transporter-1 (GLT-1) maintains low concentrations of extracellular glutamate by removing glutamate from the extracellular space. It is controversial, however, whether upregulation of GLT-1 is neuroprotective under all ischemic/hypoxic conditions. Recently, a neuroprotective effect of preconditioning with a β-lactam antibiotic ceftriaxone (CTX) that increases expression of GLT-1 has been reported in animal models of focal ischemia. On the other hand, it is said that CTX does not play a neuroprotective role in an in vitro study. Thus, we examined the effect of CTX on ischemic injury in a rat model of two-vein occlusion (2VO). This model mimics venous ischemia during, e.g. tumor sur…

MaleIschemiaAMPA receptorPharmacologyNeuroprotectionReceptors N-Methyl-D-AspartateBrain IschemiaPotassium Chloridechemistry.chemical_compoundMedicineAnimalsDrug InteractionsReceptors AMPAKainic Acidbusiness.industryGABAA receptorGeneral NeuroscienceCeftriaxoneCortical Spreading DepressionGlutamate receptorCerebral Infarctionmedicine.diseaseReceptors GABA-AAnti-Bacterial AgentsRatsNeuroprotective AgentsMuscimolchemistryExcitatory Amino Acid Transporter 2Cortical spreading depressionAnesthesiaNMDA receptorbusinessNeuroscience
researchProduct

Neuroprotection and glutamate attenuation by acetylsalicylic acid in temporary but not in permanent cerebral ischemia.

2007

To assess the effects of acetylsalicylic acid (ASA) on glutamate and interleukin-6 (IL-6) release in the striatum of rats suffering from cerebral ischemia, we used the microdialysis technique with probes implanted 2 h prior to stroke onset. A total of 36 rats were randomly assigned to either temporary (90 min, n = 18) or permanent (n = 18) middle cerebral artery occlusion (MCAO). Animals received either a bolus of 40 mg/kg ASA or saline as control 30 min after stroke onset. Permanent MCAO led to large infarct volumes with no differences between treatment with ASA (239.8 ± 4.1 mm3) and saline (230.1 ± 3.9 mm3, p = 0.15). In contrast, ASA therapy in temporary ischemia (87.2 ± 6.2 mm3) reduced…

MaleMicrodialysisTime Factorsmedicine.medical_treatmentIschemiaGlutamic AcidEnzyme-Linked Immunosorbent AssayNeuroprotectionBrain IschemiaBrain ischemiaBolus (medicine)Developmental NeurosciencemedicineAnimalscardiovascular diseasesRats WistarSalinePeroxidaseAnalysis of VarianceAspirinbusiness.industryInterleukin-6PenumbraGlutamate receptorCerebral Infarctionmedicine.diseaseRatsDisease Models AnimalNeuroprotective AgentsNeurologyGene Expression RegulationIschemic Attack TransientAnesthesiabusinessProto-Oncogene Proteins c-fosExperimental neurology
researchProduct

Prognostic value of hyperattenuating middle cerebral artery sign at CT in cerebral infarction

2004

To assess the prognostic value of hyperattenuating middle cerebral artery sign at CT in acute cerebral infarction.Ninety-two patients with acute cerebral infarction in the sylvian area were retrospectively reviewed. All patients underwent unenhanced CT 12-24 hours after the onset of symptoms and follow-up CT within 48-72 hours. Initial CT scans were evaluated by consensus by three radiologists to confirm or exclude the presence of hyperattenuating middle cerebral artery sign. History, cardiovascular risk factors and neurological impairment at discharge (mean 25 days) were recorded for each patient. The degree of disability was graded 0 (no disability) to 6 (death). Patients were divided int…

MaleMiddle Cerebral ArteryTime FactorsLogistic ModelTime FactorPrognosiHypercholesterolemiaPredictive Value of TestSex FactorFollow-Up StudieDiabetes ComplicationsSex FactorsPredictive Value of TestsRisk FactorsRetrospective StudieDiabetes ComplicationAtrial FibrillationHumansDisabled PersonsAge FactorRetrospective StudiesAgedRisk FactorAge FactorsCerebral InfarctionMiddle AgedPrognosisSurvival AnalysisLogistic ModelsAcute DiseaseHypertensionDisabled PersonFemaleSurvival AnalysiTomography X-Ray ComputedFollow-Up StudiesHuman
researchProduct